You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

149 Results
Guidelines and Advice
Feb 2016
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Drug
Mar 2021
Drug
Other Name(s): Megace® (multiple brands available)
Aug 2016
Drug
Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)
Aug 2016
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Curative
Apr 2016
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Intent: Palliative
Jun 2021
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Adjuvant, Palliative
Aug 2021

Pages